Solid Forms of The New Antitrypanosomal 1-(4-Acetamide-Benzenesulfonyl)-Benzimidazole: Preparation and Physicochemical Characterization

J Pharm Sci. 2023 Dec;112(12):3233-3239. doi: 10.1016/j.xphs.2023.09.005. Epub 2023 Sep 15.

Abstract

This study aimed to investigate the polymorphism of 1-(4-acetamide-benzenesulfonyl)-benzimidazole (PABZI), a newly developed compound with significant activity against Trypanosoma cruzi, the parasite which causes American trypanosomiasis (Chagas disease). Three different crystalline forms of PABZI [a solvent-free form (form I), three isostructural solvates (from isopropanol; acetonitrile-dichloromethane, and methanol-benzene) and a non-isostructural solvate from methanol] were isolated and characterized. The crystal structure of form I was resolved at 173 K and 300 K by single crystal X-ray diffraction. Physicochemical properties, including solubility, dissolution rate, wettability, and solid-state stability were assessed for the two most viable solid forms of PABZI, viz. form I and the isopropanol solvate (PABZI-isoOH). Form I exhibited a higher solubility and dissolution rate, and superior stability towards moisture (40 °C/75 % relative humidity) and UV-Visible light than PABZI-isoOH. Based on the solid-state stability results, form I was selected over PABZI-isoOH for further preclinical studies.

Keywords: Agglomeration; Chagas disease; Solid-state stability; Solvates; Thermal analysis; X-Ray diffractometry.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Propanol*
  • Acetamides
  • Benzimidazoles
  • Calorimetry, Differential Scanning
  • Crystallization
  • Methanol*
  • Solubility
  • Solvents / chemistry
  • X-Ray Diffraction

Substances

  • 2-Propanol
  • Methanol
  • Solvents
  • Acetamides
  • Benzimidazoles